Previous studies had demonstrated that serum biomarkers of Pro-SFTPB, CA125, Cyfra21‐1, and CEA performed well on an individual basis in the discrimination of lung cancer from healthy controls 11, 22. The gene discussed is CEACAM5; the disease is lung carcinoma.